4.7 Article

Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency

Journal

NATURE IMMUNOLOGY
Volume 13, Issue 12, Pages 1178-+

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/ni.2457

Keywords

-

Categories

Funding

  1. US National Center for Advancing Translational Sciences
  2. US National Center for Research Resources, US National Institutes of Health (NIH) [8UL1TR000043]
  3. St. Giles Foundation
  4. Jeffrey Modell Foundation
  5. Rockefeller University
  6. INSERM
  7. Paris Descartes University
  8. US National Institute of Allergy and Infectious Diseases [R21AI085523]
  9. NIH [5P01AI061093, R01AR050770]
  10. Canceropole Ile de France
  11. European Community Network of Excellence-Role of Ubiquitin and Ubiquitin-like Modifiers in Cellular Regulation [LSHC-CT-2005-018683]
  12. Thrasher Research Fund
  13. Institut de Recherches Servier
  14. Manton Foundation

Ask authors/readers for more resources

We report the clinical description and molecular dissection of a new fatal human inherited disorder characterized by chronic autoinflammation, invasive bacterial infections and muscular amylopectinosis. Patients from two kindreds carried biallelic loss-of-expression and loss-of-function mutations in HOIL1 (RBCK1), a component of the linear ubiquitination chain assembly complex (LUBAC). These mutations resulted in impairment of LUBAC stability. NF-kappa B activation in response to interleukin 1 beta (IL-1 beta) was compromised in the patients' fibroblasts. By contrast, the patients' mononuclear leukocytes, particularly monocytes, were hyper-responsive to IL-1 beta. The consequences of human HOIL-1 and LUBAC deficiencies for IL-1 beta responses thus differed between cell types, consistent with the unique association of autoinflammation and immunodeficiency in these patients. These data suggest that LUBAC regulates NF-kappa B-dependent IL-1 beta responses differently in different cell types.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available